FDA Adopts Super Intelligence Terminology

New FDA public-facing documents now use "Super Intelligence" and "SI" following a presidential executive order on federal terminology.

Updated on Nov. 16, 2026 in Artificial Intelligence

FDA Adopts Super Intelligence Terminology

The FDA began using "Super Intelligence" and "SI" in newly issued public-facing documents and communications on November 16, 2026. The change follows Executive Order 14434, which directs federal agencies to replace "Artificial Intelligence" and "AI" with the new terms in official materials.

Why it matters

The order applies to executive departments and agencies across the United States government, reflecting a federal shift in how AI-related technologies are described in official communications. The FDA notes that statutes and regulations using "artificial intelligence" or "AI" will continue to be quoted and cited as written.

Executive Order 14434 defines "Super Intelligence" and "SI" by reference to the statutory definition of artificial intelligence in 15 U.S.C. 9401(3), so the technologies covered are unchanged. The stub does not specify any technical capabilities or performance metrics associated with the renamed systems.

The players

U.S. Food and Drug Administration (FDA)

The federal agency responsible for regulating food, drugs, medical devices, and other products, which adopted the new terminology in its public-facing materials.

President of the United States

The head of the executive branch, who issued Executive Order 14434 directing federal agencies to replace "Artificial Intelligence" and "AI" with "Super Intelligence" and "SI."

The details

Executive Order 14434, titled Inaugurating the Era of Super Intelligence, was issued on September 29, 2026, and directs agencies to use the new terms to the maximum extent permitted by law. Existing guidance, regulations, and Federal Register notices remain in effect as written, while conforming terminology is applied to existing public-facing documents during their next substantive revision. Web content is updated on the FDA's regular maintenance cycle, and the order creates no new requirements for sponsors, applicants, or manufacturers.

Timeline

  1. September 29, 2026: President issues Executive Order 14434 directing agencies to adopt "Super Intelligence" and "SI."

  2. November 16, 2026: FDA begins using the new terms in newly issued public-facing documents and communications.

Roadmap

Executive Order 14434 adopts the statutory definition of artificial intelligence found in 15 U.S.C. 9401(3) and applies the label "Super Intelligence" to the same set of technologies. The change is a naming shift that leaves the legal scope of the underlying definition intact.

For people who submit materials to the FDA, the order creates no new requirements for established names, proprietary names, trade names, or labeling. Forms, electronic submission templates, and databases will be updated on normal maintenance cycles, so existing workflows should not change immediately.

The takeaway

Government terminology can change while the legal definitions behind it stay the same, so the underlying technologies and existing rules remain unaffected. Anyone reading FDA documents should expect both new labels and legacy references to appear during the transition.

Further reading

For more on how federal policy is shaping the field, see Artificial Intelligence coverage on Wisevoter.

More information

Read the FDA notice on Super Intelligence terminology under EO 14434 for the agency's full implementation details.